Surgical Technique to Minimize Positive Margins During Nerve Sparing Robotic Prostatectomy
Jason D Engel1, Arnold Schwartz*2, Carter Le1, Harold Frazier1
1George Washington University, Washington, DC;2George Washington University, Chevy Chase, MD
Introduction:
The positive margin rate for robotic prostatectomy has in most large series been inordinately high. We describe an anatomically correct, non-intuitive dissection plane that ensures maximal capsular preservation. This has led to a positive margin rate in our series of 7%, a reduction from 29% before our dissection plane modification.
Methods:
103 consecutive robotic prostatectomies were reviewed. At case 64, we changed our plane of dissection while maintaining a nerve sparing technique in all cases. (Presentation will include video)
Results:
A reduction in positive margin rate from 29.7% to 7.7% was realized. (p=.007)
| Demographics | Before change of dissection plane | After change of dissection plane | p-value |
| Number of patients | 64 | 39 | |
| | | |
| Mean age | 59.77 | 58.75 | 0.459935 |
| Mean Pre-op PSA | 6.3157 | 5.9123 | 0.527986 |
| Mean Pre-op Gleason Score | 6.2969 | 6.475 | 0.224468 |
| | | |
| Mean Post-op Gleason score | 6.4483 | 6.6757 | 0.176089 |
| Gleason 6 and under | 40 | 22 | 0.638519 |
| Gleason 3+4 | 19 | 11 | 0.873936 |
| Gleason 4+3 | 5 | 3 | 0.982579 |
| Gleason 8 and over | 2 | 4 | 0.13656 |
| Mean Pct gland involvement | 15.7407 | 18.2813 | 0.398695 |
| | | |
| Positive Margins (%) | 0.296875 | 0.076923 | 0.007009 |
Conclusions:The criticism of robotic prostatectomy that the rate of margin positivity is unacceptably high holds merit. Extreme care must be taken not to follow the natural dissection plane presented to the surgeon during the antegrade robotic approach. We have realized that there are two layers of fascia enveloping the prostate. With disciplined dissection that keeps the surgeon between these two layers, negative margins can be consistently achieved in nearly all cases without the need for nerve sacrifice. The technique we describe therefore may hold promise for allowing the robotic surgeon to achieve oncologic results comparable or better to even the most impressive open surgical series.
Back to Final Program